Market Cap 4.05B
Revenue (ttm) 2.70B
Net Income (ttm) -128.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 215.46
Profit Margin -4.74%
Debt to Equity Ratio 1.99
Volume 2,572,300
Avg Vol 2,620,598
Day's Range N/A - N/A
Shares Out 200.09M
Stochastic %K 83%
Beta 1.16
Analysts Strong Sell
Price Target $21.46

Company Profile

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. The company was founded in 2013 and is based in Orange, California.

Industry: Healthcare Plans
Sector: Healthcare
Phone: 844 310 2247
Address:
1100 West Town and Country Road, Suite 1600, Orange, United States
Theironsheikh
Theironsheikh Dec. 31 at 5:30 PM
$CLOV $ALHC absolutely thrashed us this year Clov = garbage
1 · Reply
ParadigmPulse
ParadigmPulse Dec. 25 at 5:35 PM
$ALHC This ticker is entering a stage where execution quality will overshadow headline narratives. Reliability of results matters more than short bursts of momentum. A series of confirmed wins might reduce the required risk premium. The next phase will be defined less by vision and more by delivery.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 7:18 PM
JP Morgan has updated their rating for Alignment Healthcare ( $ALHC ) to Overweight with a price target of 23.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 10 at 7:13 PM
$ALHC Current Stock Price: $19.11 Contracts to trade: $20 ALHC Dec 19 2025 Call Entry: $0.15 Exit: $0.21 ROI: 43% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Theironsheikh
Theironsheikh Nov. 25 at 10:15 PM
$CLOV $ALHC up 65% YTD $OSCR up 24% YTD This piece of shit down 23% YTD And people think Toy is a good ceo Motherfucker
4 · Reply
JarvisFlow
JarvisFlow Nov. 24 at 2:56 PM
JP Morgan has updated their rating for Alignment Healthcare ( $ALHC ) to Overweight with a price target of 20.
0 · Reply
tartanblaster
tartanblaster Nov. 21 at 9:50 AM
$CLOV before everyone panics Worth highlighting how good value current metrics puts us P/S - 0.61, 34% lower than our closest comparator $ALHC Value is even more stark when you consider enterprise value (the better metric especially since we have zero debt and reasonable cash reserves) EV/S - 0.45, 45% lower than Alignment Basically 80% upside just to equalise valuation metrics with our peers
1 · Reply
Rorx
Rorx Nov. 15 at 4:39 AM
$ALHC 18 to 21 before it crashes down to around 13 if not lower
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:29 PM
JP Morgan has adjusted their stance on Alignment Healthcare ( $ALHC ), setting the rating to Neutral with a target price of 17 → 18.
0 · Reply
IN0V8
IN0V8 Nov. 3 at 2:48 PM
$ALHC Barclays raises target price to $18 from $13
0 · Reply
Latest News on ALHC
Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

Sep 2, 2025, 2:00 PM EDT - 4 months ago

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

CI


Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 5:32 PM EST - 11 months ago

Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript


Alignment Healthcare Reports Third Quarter 2024 Results

Oct 29, 2024, 4:01 PM EDT - 1 year ago

Alignment Healthcare Reports Third Quarter 2024 Results


Alignment Healthcare Updates its Board of Directors

Aug 16, 2024, 4:30 PM EDT - 1 year ago

Alignment Healthcare Updates its Board of Directors


Alignment Healthcare Reports Second Quarter 2024 Results

Aug 1, 2024, 4:01 PM EDT - 1 year ago

Alignment Healthcare Reports Second Quarter 2024 Results


Theironsheikh
Theironsheikh Dec. 31 at 5:30 PM
$CLOV $ALHC absolutely thrashed us this year Clov = garbage
1 · Reply
ParadigmPulse
ParadigmPulse Dec. 25 at 5:35 PM
$ALHC This ticker is entering a stage where execution quality will overshadow headline narratives. Reliability of results matters more than short bursts of momentum. A series of confirmed wins might reduce the required risk premium. The next phase will be defined less by vision and more by delivery.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 7:18 PM
JP Morgan has updated their rating for Alignment Healthcare ( $ALHC ) to Overweight with a price target of 23.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 10 at 7:13 PM
$ALHC Current Stock Price: $19.11 Contracts to trade: $20 ALHC Dec 19 2025 Call Entry: $0.15 Exit: $0.21 ROI: 43% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Theironsheikh
Theironsheikh Nov. 25 at 10:15 PM
$CLOV $ALHC up 65% YTD $OSCR up 24% YTD This piece of shit down 23% YTD And people think Toy is a good ceo Motherfucker
4 · Reply
JarvisFlow
JarvisFlow Nov. 24 at 2:56 PM
JP Morgan has updated their rating for Alignment Healthcare ( $ALHC ) to Overweight with a price target of 20.
0 · Reply
tartanblaster
tartanblaster Nov. 21 at 9:50 AM
$CLOV before everyone panics Worth highlighting how good value current metrics puts us P/S - 0.61, 34% lower than our closest comparator $ALHC Value is even more stark when you consider enterprise value (the better metric especially since we have zero debt and reasonable cash reserves) EV/S - 0.45, 45% lower than Alignment Basically 80% upside just to equalise valuation metrics with our peers
1 · Reply
Rorx
Rorx Nov. 15 at 4:39 AM
$ALHC 18 to 21 before it crashes down to around 13 if not lower
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:29 PM
JP Morgan has adjusted their stance on Alignment Healthcare ( $ALHC ), setting the rating to Neutral with a target price of 17 → 18.
0 · Reply
IN0V8
IN0V8 Nov. 3 at 2:48 PM
$ALHC Barclays raises target price to $18 from $13
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 2:20 PM
Barclays has updated their rating for Alignment Healthcare ( $ALHC ) to Equal-Weight with a price target of 18.
0 · Reply
IN0V8
IN0V8 Oct. 31 at 6:53 PM
$ALHC Buy Leerink Partners raises PT to $23 from $20 Stephens raises target price to $24 from $20 UBS raises target price to $18 from $17
0 · Reply
tartanblaster
tartanblaster Oct. 31 at 1:34 PM
$CLOV $ALHC Doing well after very strong earnings yesterday Should give us some confidence that medical cost inflation has levelled us and hopefully see us reporting similarly storing earnings
2 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 30 at 9:31 PM
0 · Reply
Cash_Only_Account
Cash_Only_Account Oct. 30 at 8:40 PM
$CLOV $ALHC Alignment Healthcare banging it. https://finance.yahoo.com/quote/ALHC/
0 · Reply
tartanblaster
tartanblaster Oct. 30 at 11:47 AM
$CLOV $ALHC earnings are the ones to watch today after hours. The closest comparator to Clover, what trends they've seen in medical costs will give us best idea of what to expect on Nov 4th
0 · Reply
Helpmrwizard
Helpmrwizard Oct. 28 at 9:12 PM
$ALHC this looks like it could explode to the upside in a few weeks; call option premiums are hefty all the way to $30 per share, chart looks great
0 · Reply
Gorohanada
Gorohanada Oct. 21 at 3:13 PM
$ALHC has best ratings for adult care
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 12:36 PM
Goldman Sachs updates rating for Alignment Healthcare ( $ALHC ) to Buy, target set at 21.
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Oct. 8 at 7:01 PM
$ALHC $3.34B mc founder-led 👑 $XLV Hidden Gem 💎 (just 283 watchers on @stocktwits !) rotating up above a fresh gold-cross and rising 80-week SMA. Picture perfect base and volume profile - Pct of all funds at Record highs & rising 🏦 - AI Council is BULLISH with a BUY recommendation 🐂✅ TrendEdge.app/asset/ALHC cc @WAJeff @MaverikIT
0 · Reply
tartanblaster
tartanblaster Oct. 3 at 12:49 PM
$CLOV as painful as this week has been, it won't last When we recover it will be rapid, the valuation fundamentals don't lie. Currently sitting at a P/S of 0.79, and EV/REV (my preferred as reflects our lack of debt) of 0.6. Vs closest comparator of $ALHC of 0.95 & 0.9 Mad that $CLOV growing at 35%+ per annum has worth valuation metrics than $UNH ! (0.87 EV/REV)
0 · Reply
MBNYC11
MBNYC11 Oct. 1 at 4:41 PM
$CLOV plan design was released on http://Medicare.gov, I am thinking market is getting scared with low premium but low deductible and overall good benefits. Therefore the market is pricing in anti selection for next year - time will tell if they got pricing right. $ALHC is trending the same way. If you’re bullish on next gen MA plans then you are in the right place.
0 · Reply